Photo from wikipedia
Alopecia areata (AA) is a chronic autoimmune skin disease with hair loss, which often results in a poor prognosis. Although the high-dose intravenous methylprednisolone pulse therapy (IVMP) is used for… Click to show full abstract
Alopecia areata (AA) is a chronic autoimmune skin disease with hair loss, which often results in a poor prognosis. Although the high-dose intravenous methylprednisolone pulse therapy (IVMP) is used for AA, predictive factors affecting efficacies of IVMP are not fully elucidated. Thus, we conducted a retrospective study reviewing IVMP for AA during January 2009 and December 2018. The study was approved by the ethical committee of the Tohoku University Graduate School of Medicine.
Keywords:
study;
retrospective study;
methylprednisolone pulse;
pulse therapy;
alopecia areata;
high dose
Journal Title: British Journal of Dermatology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Dermatology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!